Tbx21-flox Mouse
Common Name
Tbx21-flox
제품 ID
S-CKO-18354
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-57765-Tbx21-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Tbx21-flox Mouse (카탈로그 번호 S-CKO-18354)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Tbx21-flox
품종 계통계통 ID
CKOCMP-57765-Tbx21-B6J-VB
유전자명
제품 ID
S-CKO-18354
유전자 별칭
TBT1, Tbet, Tblym
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 11
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000001484
NCBI 전사체 ID
NM_019507
타겟 영역
Exon 2~3
유효 영역 크기
~2.8 kb
유전자 연구 개요
TBX21, also known as T-bet, is a crucial transcription factor that plays a vital role in coordinating the type 1 immune response. It is involved in multiple biological processes and has been associated with various disease-related pathways [1,2,3,4,5,8].
In colorectal cancer, TBX21 expression is decreased compared to normal tissue, and is negatively correlated with TNM stages. Ectopic expression of TBX21 inhibits cell proliferation, promotes apoptosis, and suppresses metastasis both in vitro and in vivo, via ARHGAP29/RSK/GSK3β-dependent and MYCT1/ZO-1 signaling-dependent manners [1,7]. In microsatellite-stable colorectal cancer, Fusobacterium nucleatum can induce Tbx21 promoter H3K27 acetylation and expression in CD8+ T cells, and TBX21 transcriptionally represses PD-1, alleviating CD8+ T cell exhaustion and promoting effector function, thus facilitating anti-PD-1 therapy [2]. In CMS1 subtype colorectal cancer, high TBX21 expression and low methylation are associated with a survival advantage, and it may be regulated by the TP53/P53 pathway [3].
In late-onset Alzheimer's disease, TBX21 mRNA expression is elevated in the leukocytes of peripheral blood, and the TT genotype of rs41515744 plays a protective role [4]. In periapical lesions, the TBX21-1993 T allele and TC/CC genotypes predispose to Th1-type immune response development in vitro and influence immune response polarization in vivo [5]. In Asian seabass, tbx21 is associated with resistance against viral nervous necrosis (VNN), with overexpression reducing NNV replication [6].
In obesity, ablation of Tbx21 specifically in B cells reduces inflammatory cytokines and macrophages in adipose tissue, ameliorating metabolic symptoms [8]. In Japanese patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), PTCL-TBX21 shows different clinicopathological features and better prognosis compared to PTCL-GATA3 [9].
In conclusion, TBX21 is essential for the type 1 immune response and is involved in numerous disease-related processes. Studies, including those using in vivo models (although not all are KO/CKO mouse models), have revealed its role in cancers, neurodegenerative diseases, inflammatory conditions, and infectious diseases in fish, providing insights into potential therapeutic targets and disease mechanisms.
References:
1. Jiang, Xinyu, Du, Wenfei, Yang, Chenglong, Huang, Yongming, Shen, Wenzhi. 2023. TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner. In Cellular oncology (Dordrecht, Netherlands), 46, 1269-1283. doi:10.1007/s13402-023-00809-6. https://pubmed.ncbi.nlm.nih.gov/37067748/
2. Wang, Xueliang, Fang, Yi, Liang, Wei, Sung, Joseph J Y, Yu, Jun. 2024. Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer. In Cancer cell, 42, 1729-1746.e8. doi:10.1016/j.ccell.2024.08.019. https://pubmed.ncbi.nlm.nih.gov/39303724/
3. Shen, Yuanyuan, Nussbaum, Yulia I, Manjunath, Yariswamy, Shyu, Chi-Ren, Mitchem, Jonathan B. 2022. TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer. In Cancers, 14, . doi:10.3390/cancers14194594. https://pubmed.ncbi.nlm.nih.gov/36230517/
4. Fatemi Langroudi, S R, Zeinaly, M, Ajamian, F. 2023. TBX21, the Master regulator of the type 1 immune response, overexpresses in the leukocytes of peripheral blood in patients with late-onset Alzheimer's disease. In Immunity & ageing : I & A, 20, 59. doi:10.1186/s12979-023-00385-1. https://pubmed.ncbi.nlm.nih.gov/37950255/
5. Colavite, Priscila Maria, Cavalla, Franco, Garlet, Thiago Pompermaier, Silva, Renato Menezes, Garlet, Gustavo Pompermaier. 2018. TBX21-1993T/C polymorphism association with Th1 and Th17 response at periapex and with periapical lesions development risk. In Journal of leukocyte biology, 105, 609-619. doi:10.1002/JLB.6A0918-339R. https://pubmed.ncbi.nlm.nih.gov/30548981/
6. Wong, Joey, Yang, Zituo, Wang, Le, Sun, Fei, Yue, Gen Hua. 2024. Tbx21 gene and its association with resistance against viral nervous necrosis (VNN) in Asian seabass, Lates calcarifer. In Marine life science & technology, 6, 679-689. doi:10.1007/s42995-024-00234-0. https://pubmed.ncbi.nlm.nih.gov/39620089/
7. Yang, Xiaowen, Shen, Xinzhuang, Liu, Zongjun, Huang, Yongming, Shen, Wenzhi. 2025. TBX21 inhibits colorectal cancer metastasis through ARHGAP29/GSK3β inhibitory signaling- and MYCT1/ZO-1 signaling-dependent manner. In International journal of biological sciences, 21, 328-345. doi:10.7150/ijbs.97920. https://pubmed.ncbi.nlm.nih.gov/39744435/
8. Hägglöf, Thomas, Vanz, Carlo, Kumagai, Abigail, Shute, Travis, Leadbetter, Elizabeth A. 2022. T-bet+ B cells accumulate in adipose tissue and exacerbate metabolic disorder during obesity. In Cell metabolism, 34, 1121-1136.e6. doi:10.1016/j.cmet.2022.07.002. https://pubmed.ncbi.nlm.nih.gov/35868310/
9. Shimasaki, Yasumasa, Miyoshi, Hiroaki, Kawamoto, Keisuke, Suzuki, Ritsuro, Ohshima, Koichi. 2024. Clinicopathological comparison between PTCL-TBX21 and PTCL-GATA3 in Japanese patients. In Cancer medicine, 13, e6793. doi:10.1002/cam4.6793. https://pubmed.ncbi.nlm.nih.gov/38234210/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
